C
콜마바이오텍
215380KOSDAQ40.5 / 100
Reference Date: 2026-10-23
Financial Score9.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, Operating Profit is on a declining trend. Slightly down 2.8% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Ujeong Bio operates in two main business areas: Bio Business and Infection Control Business, offering services such as biological indicator (BI) testing, genetic toxicity evaluation, and SPR analysis. The biotech industry is growing rapidly due to advancements in oncology drugs, immunotherapy, and obesity treatments, supported by government initiatives and increasing demand for pharmaceutical innovation.
Number of Employees
127people
Average Salary
50.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.51Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
-21.03Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
142.65Industry Average 100.002.0Point
Higher than industry avg (caution)
Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼0.6% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼89.4% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -13.2% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (18%, downtrend)
Current 2,095Won52-week high 3,60552-week low 1,753
1-month return2.0Point
1m -2.78% (slight drop)
Volume trend6.0Point
Volume surge
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0